Leads strategic sourcing and evaluation of early-stage innovation in haematology, from preclinical to Phase 1 assets. Drives due diligence, shapes partnering strategies, and executes transactions in collaboration with Business Development. Embedded in the Therapeutic Area Leadership Team to influence portfolio planning and external innovation priorities.
The Associate Director, Biostatistics, leads statistical contributions to clinical development programs, including study design, data analysis, and regulatory submissions. They collaborate with cross-functional teams, manage outsourcing, and ensure the quality and timeliness of deliverables.
Lead the scientific design and execution of interventional clinical studies within Medical Affairs, ensuring alignment with strategic evidence plans and regulatory standards. Provide medical governance, oversee study protocols and data interpretation, and collaborate with cross-functional teams and external stakeholders. Engage with investigators and thought leaders to enhance study design and contribute to publications and regulatory submissions.
Leads clinical development for vascular programmes across early and late phases, shaping study designs and clinical development plans. Works cross-functionally with translational science, regulatory, and commercial teams to advance medicines for vascular disease, with a focus on patient impact and scientific innovation. Provides medical oversight, contributes to regulatory submissions, and guides decision-making in a matrix environment.
Lead clinical pharmacology strategy for small molecule programs in oncology and non-oncology areas, designing and executing studies from Phase 1 through late development. Utilize AI-driven models for PK/PD prediction, dose optimization, and regulatory submissions, while managing CROs and translating preclinical data into human dosing strategies.
Lead a team of computational biologists to identify and validate novel oncology targets using integrated phenomics, transcriptomics, genomics, and proteomics data. Develop and scale methods for target discovery in oncology and immunological diseases, collaborating closely with biologists, data scientists, and engineers. Drive data strategy and present findings to stakeholders to advance drug discovery programs.
This is a general talent network sign-up opportunity rather than a specific job role. Candidates can submit their resume for future consideration at Recursion, a clinical-stage TechBio company using AI and automated biology to accelerate drug discovery. The company emphasizes bold, ethical innovation and cross-functional collaboration to address unmet medical needs.
The Cell Therapy Account Executive (CTAE) is responsible for developing and maintaining strong relationships with Advanced Therapy Treatment Centers (ATTCs) in the South UK. Key responsibilities include driving the utilization of Autolus' CAR T therapies, coordinating cross-functional activities, and ensuring a seamless customer experience. The role involves significant travel within the UK and requires deep clinical expertise in haematology and oncology.
The Cell Therapy Account Executive (CTAE) is responsible for building and maintaining strong relationships with Advanced Therapy Treatment Centers (ATTCs) in the South UK. The role involves coordinating Autolus' activities within the ATTCs, ensuring seamless customer experiences, and driving the utilization of Autolus' CAR T therapies. The CTAE will work closely with cross-functional teams to develop strategic account plans and provide clinical support to healthcare professionals.
This role involves leading scientific strategy and execution for immunogenicity and ligand binding assays (LBA) in support of Moderna’s mRNA-LNP therapeutic programs. The Principal Scientist will oversee regulated bioanalytical activities including assay development, validation, and sample analysis, ensuring compliance with GcLP, GLP, and GCP standards. The position plays a key role in clinical development by generating high-quality data to inform regulatory submissions and advance innovative medicines, with opportunities to engage in AI-enabled and digital analytical approaches.
This role involves developing and executing biochemical and molecular biology assays to support pharmacokinetic/pharmacodynamic analysis. Responsibilities include assay development, data analysis, and collaboration with external partners, while staying current with scientific literature and regulatory guidelines.
This role involves working directly with pharmaceutical and biotechnology companies to design, build, and deploy production-grade AI solutions for complex scientific problems. Responsibilities include tailoring Owkin’s AI platform, K Pro, to client needs, translating biological questions into computational workflows, and collaborating with cross-functional teams to ensure high-quality scientific insights.
Lead DMPK strategy for drug discovery projects using an AI-first approach, integrating quantitative pharmacology and ADME data to guide candidate selection. Collaborate with chemistry, pharmacology, and machine learning teams to optimise molecule design and advance predictive models. Contribute to regulatory documentation and drive innovation in human PK prediction and biotransformation understanding.
This role involves owning the peptide and protein platform as a commercial product, conducting market and competitive intelligence, defining target product profiles, and shaping the go-to-market strategy. The role requires a deep understanding of peptide therapeutics and the ability to bridge technical and commercial conversations with pharmaceutical partners.
The role involves conducting molecular virology research, focusing on the interactions between viruses and host cells, particularly in the context of cellular oxygen sensing. Responsibilities include maintaining viral cultures, performing molecular biology techniques, and contributing to experimental design and data analysis.
